HAIER BIOMEDICAL(688139) 搜狐财经·2025-05-09 12:00Core Viewpoint - Haier Biomedical's stock closed at 31.9 yuan, down 1.09%, with a rolling PE ratio of 29.90 times, and a total market value of 10.143 billion yuan [1] Group 1: Company Overview - Haier Biomedical focuses on providing optimal user experiences for life science users, including pharmaceutical companies, research institutions, and healthcare users [2] - The company has developed two main business segments: life sciences and medical innovation, offering comprehensive digital solutions such as smart laboratories and digital hospitals [2] - Key products include low-temperature storage boxes, automated biological sample storage systems, and various automated medication products [2] Group 2: Financial Performance - In the first quarter of 2025, the company reported revenue of 689 million yuan, a year-on-year increase of 0.30%, and a net profit of 110 million yuan, a year-on-year decrease of 19.88% [3] - The gross profit margin for sales was 48.35% [3] Group 3: Market Position - The average PE ratio for the medical device industry is 48.98 times, with a median of 36.16 times, placing Haier Biomedical at the 70th position in the industry [1][3] - As of the first quarter of 2025, 14 institutions held shares in Haier Biomedical, with a total holding of 200.17 million shares valued at 6.922 billion yuan [1]